Blog

UK private equity firm Inflexion has completed a buyout of global beauty business Pangea Laboratories. The company reportedly values ​​the deal at over £ 150m. The professional service company Alantra advised Pangea shareholders on the investment.

Founded in 1999 by Elliot Isaacs, Pangea Laboratories is a fast growing beauty company with a start-up culture based on a disruptive model. The organization that owns Medik8, a premium skin care brand focused on science-based products related to skin aging. Thanks to the expertise of Medik8 them to develop a range of high performance skin care products, which focus on vitamin C, sunscreen and vitamin A, their “CSA” philosophy.

Pangea took advantage of this high-performance model to achieve, according to sources, last year a turnover of 20 million pounds, and the Covid-19 crisis secured despite the greater impact of a strong performance. As a result of this performance, Pangea has attracted investment from UK private equity firm Inflexion, which has completed a buyout of the global beauty business.

As reported by the online news platform AltAssets, the deal is said to be between 150 and 200 million pounds sterling. Inflexion closed the deal with his Buyout Fund V in the amount of 1.25 billion GBP from which it in May 2018 along with its Partnership Capital Fund II in the amount of 1 billion GBP graduated.

Commenting on the news, Elliot Isaacs said, “Over the past three years the brand has seen phenomenal growth as the skin care consumer becomes more informed and turned to science and ingredients. We are very excited to partner with Inflexion who have the passion and expertise to accelerate the brand’s international ambitions. “

Simon Turner, Managing Partner of Inflexion, added, “Medik8’s science-based approach to skin care, combined with its sustainability traits, makes it an incredibly impressive company. We look forward to working closely with the entire team to the business to scale further by improving the digital launch of routes and support the continuous innovation, the introduction of new products and international expansion. “

Pangea shareholders were advised on the investment by experts from Alantra. The independent global midsize investment advisory firm commissioned a team of Chris Bates, Oliver Hickley, Saro Djerrahian and Matthew Wiseman with this task.

Wiseman, partner at Alantra, stated, “We are delighted to have achieved an exceptional result for such a great team and brand. Inflexion will be a great partner for Medik8 and their investment will allow management to continue investing in innovation, capitalizing on the growth potential in both e-commerce and professional sectors, and continuing its global growth. “